The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Episodes of worsening symptoms and signs characterize the clinical course of patients with
chronic heart failure (HF). These events are associated with poorer quality of life, increased …

Acute heart failure is a major cause of urgent hospitalizations. These are followed by marked
increases in death and rehospitalization rates, which then decline exponentially though they …

Aims In AFFIRM‐AHF, intravenous ferric carboxymaltose (FCM) reduced heart failure (HF)
hospitalisations and improved quality of life versus placebo in iron‐deficient patients …

Aim Prevention of heart failure (HF) hospitalisations and deaths constitutes a major
therapeutic aim in patients with HF. The role of telemedicine in this context remains …

Background Acute heart failure is a public health concern. This study systematically
reviewed randomized clinical trials (RCTs) to evaluate vasodilators in acute heart failure …

Heart failure (HF) prevalence remains high worldwide with significant sex-related and
regional differences in its presentation, management, and outcomes. In 2020, advances in …

Patients hospitalized for heart failure with reduced ejection fraction (HFrEF) can be divided
into those with de novo heart failure (HF) versus those with worsening chronic heart failure …